Skip to main content

Table 2 IPD identification process of included IPD-NMAs

From: Statistical analyses and quality of individual participant data network meta-analyses were suboptimal: a cross-sectional study

Items

Frequency

Proportion (%)

Methods used to identify IPD eligible studies (n = 21)

 Collaborative groupa

12

57.1

 Systematic review and contacting authors

7

33.3

 Other methodsb

2

9.5

Did the authors obtain IPD from all studies or just a subset? (n = 21)

 All studies

7

33.3

 Not reported

14

66.7

IPD-NMAs that identified IPD through systematic reviews (n = 7)

 Proportion of contacted authors provided IPD

  46.8%

1

14.3

  70.0%

1

14.3

  80.0%

1

14.3

  Not reported

4

57.1

 Whether a literature search was conducted? (yes)

7

100.0

 Number of databases searched

  

  2 to 5

3

42.9

  6 to 9

3

42.9

  14

1

14.3

 Name of database

  PubMed/MEDLINE

6

85.7

  Cochrane Library

6

85.7

ClinicalTrials.gov

6

85.7

  EMBASE

4

57.1

  Web of Science

2

28.6

  ICRTP

2

28.6

 Reported the year of retrieval of databases

6

85.7

 Presented search strategy

3

42.9

  Online supplement

1

14.3

  Manuscript

1

14.3

  Previous published study

1

14.3

  1. IPD individual participant data, IPD-NMAs individual participant data network meta-analyses, ICRTP World Health Organization International Clinical Trials Registry Platform
  2. aIPD-NMAs project team included authors of IPD studies
  3. bOther methods mean obtaining IPD from the Yale Open Data Access Project and a previous meta-analysis